Proteomic identification and early validation of complement 1 inhibitor and pigment epithelium-derived factor: Two novel biomarkers of Alzheimer's disease in human plasma.
about
Blood-Based Proteomic Biomarkers of Alzheimer's Disease PathologySerping1/C1 Inhibitor Affects Cortical Development in a Cell Autonomous and Non-cell Autonomous Manner.Blood-based biomarkers of Alzheimer's disease: challenging but feasibleDifferential network analyses of Alzheimer's disease identify early events in Alzheimer's disease pathologyPlasma proteins predict conversion to dementia from prodromal diseaseAssociation of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease.Elevated plasma levels of pigment epithelium-derived factor correlated with inflammation and lung function in COPD patientsMatricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localizationAssessing candidate serum biomarkers for Alzheimer's disease: a longitudinal study.The Alzheimer's disease peptide β-amyloid promotes thrombin generation through activation of coagulation factor XII.Alzheimer's disease: are blood and brain markers related? A systematic review.Changes in the plasma proteome at asymptomatic and symptomatic stages of autosomal dominant Alzheimer's diseasePlasma protein profiling of Mild Cognitive Impairment and Alzheimer's disease using iTRAQ quantitative proteomics.Industrialized MS-based proteomics in the search for circulating biomarkers.Plasma biomarkers for Alzheimer's disease: much needed but tough to find.Finding a pathological diagnosis for Alzheimer's disease: are inflammatory molecules the answer?Progress towards a consensus on biomarkers for Alzheimer's disease: a review of peripheral analytes.Discovery and Subsequent Confirmation of Novel Serum Biomarkers Diagnosing Alzheimer's Disease.
P2860
Q26774743-19165BBC-3BFE-4BAC-8E06-0AEDBB863661Q33804415-BE92DA0A-D566-4297-89B4-917BC426FC3DQ33824444-BC3DC8D7-FC73-45E8-9F6E-D30DE29BE62AQ34043551-1785DDFA-2775-48DA-84E4-8640341F260FQ34556953-24AD725E-4C12-4B62-AE72-912F016EA022Q35034130-6869420F-CA40-4255-9E30-7649BAB8ABC2Q35201511-98872ACB-D15C-4F04-B2F5-6EEAF1E4246EQ36578825-ADC5E342-BE8D-4EED-9E71-C44D6CA7CCAEQ36740479-BF814B89-D741-4169-A73B-AFEEB08576BFQ36909451-0FCD4CA6-8B2D-4860-93DD-A5355984B2D1Q36966044-4F468DA9-21C2-4BBE-9521-1A912F79D0D1Q37067687-A784603A-8442-4A28-850A-705810654318Q37504001-82F76B8E-BADD-45B9-8DEB-7F7F1ED44B52Q37810154-C3D0A1AC-4565-442D-9EF9-DEF63797C666Q38037157-52C0495B-6121-4246-91C6-DF9811D8428DQ38060638-0CEB9D0C-DE53-4BB0-8B69-E6ADB96AB6A3Q38125769-F1136787-55A7-4BBF-9061-771E35445B68Q53481618-FC9987B3-571B-4A83-A9F4-1E748F1A130A
P2860
Proteomic identification and early validation of complement 1 inhibitor and pigment epithelium-derived factor: Two novel biomarkers of Alzheimer's disease in human plasma.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Proteomic identification and e ...... mer's disease in human plasma.
@en
Proteomic identification and e ...... mer's disease in human plasma.
@nl
type
label
Proteomic identification and e ...... mer's disease in human plasma.
@en
Proteomic identification and e ...... mer's disease in human plasma.
@nl
prefLabel
Proteomic identification and e ...... mer's disease in human plasma.
@en
Proteomic identification and e ...... mer's disease in human plasma.
@nl
P2093
P2860
P356
P1476
Proteomic identification and e ...... imer's disease in human plasma
@en
P2093
A Jacqueline Hunter
Allen D Roses
Christine M Debouck
Darren A Gormley
David R Willé
Deborah M Briggs
Emma E Kinsey
Emma L Akuffo
Israel S Gloger
Jill C Richardson
P2860
P304
P356
10.1002/PRCA.200780101
P577
2008-03-07T00:00:00Z